Cellular Biomedicine Group
530 University Avenue
Suite 17
Palo Alto
California
94301
United States
Tel: 1-650-566-5064
Website: http://www.cellbiomedgroup.com
136 articles about Cellular Biomedicine Group
-
Cellular Biomedicine Group Featured on Wide World of Stocks Television
5/12/2015
-
Cellular Biomedicine Group Responds To Purported Class Action Lawsuit
5/1/2015
-
Cellular Biomedicine Group Appoints Two New Members To Scientific Advisory Board
4/30/2015
-
Cellular Biomedicine Group To Present Cancer CAR-T CD30 Therapy Clinical Development Program At The 10th Annual World Stem Cells & Regenerative Medicine Congress In London, UK
4/27/2015
-
Silicon Valley's Cellular Biomedicine Group Expands in Beijing With New Facility and Plans to Hire
4/22/2015
-
Cellular Biomedicine Group Engages Huntsworth Health To Build Global KOL Advocacy For Knee Osteoarthritis Stem Cell Rejoin(TM) Clinical Trials
4/20/2015
-
Cellular Biomedicine Group To Present At 10th Annual World Stem Cells & Regenerative Medicine Congress In London, UK
4/17/2015
-
Cellular Biomedicine Group Announces Participation In Jefferies and Co. 2015 Global Healthcare Conference
4/16/2015
-
Cellular Biomedicine Group Upgraded To NASDAQ Global Market
4/10/2015
-
Cellular Biomedicine Group To Present At Chinabio Partnering Forum In Shanghai On April 16, 2015
4/10/2015
-
Cellular Biomedicine Group Responds To False Statements And Allegations Made By Short Seller
4/8/2015
-
Cellular Biomedicine Group Hosts Open House Titled "Advancing Solutions To Cancerous And Degenerative Straits" On April 17, 2015
4/8/2015
-
Cellular Biomedicine Group Announces Closing Of $19.6 Million Private Placement Offering
4/7/2015
-
Cellular Biomedicine Group's Shanghai Facility Passes Fourth Consecutive CFDA Inspection
4/6/2015
-
Cellular Biomedicine Group Reports Full-Year And Fourth Quarter 2014 Financial Results
3/31/2015
-
Cellular Biomedicine Group Announces Phase I Results From CAR-T Immuno-Oncology Clinical Development Programs
3/25/2015
-
Cellular Biomedicine Group Announces Interim Results From Phase IIb Clinical Trial For Knee Osteoarthritis Stem Cell Rejoin Therapy
3/25/2015
-
Cellular Biomedicine Group To Present Osteoarthritis Stem Cell Rejoin Therapy And Cancer CAR-T Therapy Clinical Development Programs At The 2015 Annual Regen Med Investor Day
3/18/2015
-
Week in Review: Cellular Biomedicine Group In-Licenses Cancer Immunotherapy From China
2/16/2015
-
Cellular Biomedicine Group Acquiring Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) Immuno-Oncology Technology And Clinical Data
2/9/2015